A Medical Device Daily
Affymetrix (Santa Clara, California) and Children’s Research Institute (Milwaukee, Wisconsin) reported they have entered into a five-year strategic alliance to help Children’s Research build processing capacity to analyze up to 25,000 samples using several different Affymetrix arrays.
The goal of the alliance is to demonstrate the clinical utility of array-based molecular diagnostics and to leverage arrays to make molecular diagnostic tests better, faster and more economical.
Scientists at Children’s Research will use Affymetrix’s GeneChip microarray technology to analyze the genomic information of consenting patients. Large-scale clinical studies are designed to enable researchers to better identify the genetic variations associated with common, complex diseases that affect children and use the resulting information to develop diagnostic and screening tests.
“The primary objective of Children’s Research Institute is to bring together the best in cutting-edge medical research with the best in established medical treatment for children,” said Robert Kliegman, MD executive VP of Children’s Research.
Affymetrix says that its GeneChip microarray technology helps researchers diagnose and tailor treatments for individual patients by identifying and measuring the genetic information associated with complex diseases.
Children’s Research is a not-for-profit research organization of Children’s Hospital and Health System affiliated with Medical College of Wisconsin (Madison).